Weekly Comment
Sex, pills and bad information
The Internet is offering a wealth of information to more and more people, but also an avenue for irresponsible businesses to exploit consumer health concerns.
Weekly Comment
The Internet is offering a wealth of information to more and more people, but also an avenue for irresponsible businesses to exploit consumer health concerns.
XanGo, the maker of a xanthone-rich dietary supplement from mangosteen, is seeking to build awareness of the 'superfruit' and is advocating the use of whole fruit claims only where they are truly merited.
Israeli biotech Enzymotec has signed an agreement with Il Dong to take CardiaBeat into South Korea, under which they will develop biofunctional consumer products for cognitive function and heart health.
Marinova's new fucoidan facility in Hobart, Tasmania, is on schedule to commence operations from next month, offering fucoidans from a broader range of microalgae species for nutraceutical and cosmetics use.
Tocotrienols, the least studied form of vitamin E, can achieve levels in the blood that may give protection against a wide range of diseases such as cancer and stroke, says a new study from the US.
The findings of a recent CRN survey, in which more than half of adults said they do not stick to a healthy balanced diet, underscore a need to help consumers make the motivational jump from knowing to doing.
Companies involved in a 1990s global vitamin cartel have reached a A$30.5m (€18.2m) settlement with plaintiffs in a class action suit to brought by individuals and companies who claimed to have suffered losses as a result of price-fixing.
EuroPharma's recently launched fish oil extract Vectomega could led to improvements in cholesterol levels, according to a pilot clinical trial, with more trials planned to build up the science behind the product.